These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21708084)

  • 1. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
    Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
    Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
    McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
    Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 May; 117(5):609-14. PubMed ID: 10326957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
    JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
    Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.
    Boldt HC; Melia BM; Liu JC; Reynolds SM;
    Ophthalmology; 2009 Jan; 116(1):106-115.e1. PubMed ID: 19118701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early macular morphological changes following plaque radiotherapy for uveal melanoma.
    Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA
    Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following 125I-Plaque Brachytherapy for Uveal Melanoma.
    Tamplin MR; Deng W; Garvin MK; Binkley EM; Hyer DE; Buatti JM; Ledolter J; Boldt HC; Kardon RH; Grumbach IM
    Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):3. PubMed ID: 33393969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late complications after brachytherapy of I-125 uveal melanoma].
    Kowal J; Romanowska-Dixon B
    Klin Oczna; 2016; 118(3):226-30. PubMed ID: 30088387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The analysis of I125 brachytherapy complications in cases of uveal melanoma].
    Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U
    Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
    van Ginderdeuren R; van Limbergen E; Spileers W
    Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.